These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33888524)

  • 1. Interstitial lung disease increases susceptibility to and severity of COVID-19.
    Lee H; Choi H; Yang B; Lee SK; Park TS; Park DW; Moon JY; Kim TH; Sohn JW; Yoon HJ; Kim SH
    Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 33888524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis.
    Ouyang L; Gong J; Yu M
    Int Immunopharmacol; 2021 Nov; 100():108145. PubMed ID: 34547678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Coronavirus Disease 2019 Occurrence, Severe Presentation, and Mortality in Patients with Lung Cancer.
    Yang B; Choi H; Lee SK; Chung SJ; Yeo Y; Shin YM; Park DW; Park TS; Moon JY; Kim TH; Sim YS; Yoon HJ; Sohn JW; Lee H; Kim SH
    Cancer Res Treat; 2021 Jul; 53(3):678-684. PubMed ID: 33421983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
    Drake TM; Docherty AB; Harrison EM; Quint JK; Adamali H; Agnew S; Babu S; Barber CM; Barratt S; Bendstrup E; Bianchi S; Villegas DC; Chaudhuri N; Chua F; Coker R; Chang W; Crawshaw A; Crowley LE; Dosanjh D; Fiddler CA; Forrest IA; George PM; Gibbons MA; Groom K; Haney S; Hart SP; Heiden E; Henry M; Ho LP; Hoyles RK; Hutchinson J; Hurley K; Jones M; Jones S; Kokosi M; Kreuter M; MacKay LS; Mahendran S; Margaritopoulos G; Molina-Molina M; Molyneaux PL; O'Brien A; O'Reilly K; Packham A; Parfrey H; Poletti V; Porter JC; Renzoni E; Rivera-Ortega P; Russell AM; Saini G; Spencer LG; Stella GM; Stone H; Sturney S; Thickett D; Thillai M; Wallis T; Ward K; Wells AU; West A; Wickremasinghe M; Woodhead F; Hearson G; Howard L; Baillie JK; Openshaw PJM; Semple MG; Stewart I; Jenkins RG;
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1656-1665. PubMed ID: 33007173
    [No Abstract]   [Full Text] [Related]  

  • 5. Mortality in patients with interstitial lung diseases hospitalized by severe or critical COVID-19.
    Pruneda AKS; Barreto-Rodríguez JO; Selman M; Juárez-Hernández F; Buendía-Roldán I
    BMC Pulm Med; 2023 Oct; 23(1):388. PubMed ID: 37828511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of newly diagnosed interstitial lung disease after COVID-19 and impact of vaccination: a nationwide population-based cohort study.
    Kim BG; Lee H; Jeong CY; Yeom SW; Park DW; Park TS; Moon JY; Kim TH; Sohn JW; Yoon HJ; Kim JS; Kim SH
    Front Public Health; 2023; 11():1295457. PubMed ID: 38259763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic.
    Guiot J; Henket M; Frix AN; Delvaux M; Denis A; Giltay L; Thys M; Gester F; Moutschen M; Corhay JL; Louis R;
    Respir Investig; 2020 Nov; 58(6):437-439. PubMed ID: 32978099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.
    Oh TK; Song IA
    BMC Pulm Med; 2021 Jan; 21(1):12. PubMed ID: 33407347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease.
    Strykowski RK; Poonawalla M; Tyker A; Bauer Ventura I; Lee C; Jablonski R; Vij R; Chung J; Strek M; Adegunsoye A
    Cureus; 2022 Apr; 14(4):e23808. PubMed ID: 35530871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).
    Gagiannis D; Steinestel J; Hackenbroch C; Schreiner B; Hannemann M; Bloch W; Umathum VG; Gebauer N; Rother C; Stahl M; Witte HM; Steinestel K
    Front Immunol; 2020; 11():587517. PubMed ID: 33123171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
    Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.
    Kudoh S; Kato H; Nishiwaki Y; Fukuoka M; Nakata K; Ichinose Y; Tsuboi M; Yokota S; Nakagawa K; Suga M; ; Jiang H; Itoh Y; Armour A; Watkins C; Higenbottam T; Nyberg F
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1348-57. PubMed ID: 18337594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and acute exacerbation of interstitial lung disease.
    Kondoh Y; Kataoka K; Ando M; Awaya Y; Ichikado K; Kataoka M; Komase Y; Mineshita M; Ohno Y; Okamoto H; Ooki T; Tasaka Y; Tomioka H; Suda T
    Respir Investig; 2021 Sep; 59(5):675-678. PubMed ID: 34272158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [When COVID-19 encounters interstitial lung disease: challenges and management].
    Ren YH; Wang SY; Liu M; Guo YM; Dai HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Aug; 43(8):633-638. PubMed ID: 32198915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease.
    Johnston J; Dorrian D; Linden D; Stanel SC; Rivera-Ortega P; Chaudhuri N
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Concise Review 2020: Interstitial lung disease.
    Teoh AKY; Corte TJ
    Respirology; 2021 Jun; 26(6):604-611. PubMed ID: 33913200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).
    Wild JM; Porter JC; Molyneaux PL; George PM; Stewart I; Allen RJ; Aul R; Baillie JK; Barratt SL; Beirne P; Bianchi SM; Blaikley JF; Brooke J; Chaudhuri N; Collier G; Denneny EK; Docherty A; Fabbri L; Gibbons MA; Gleeson FV; Gooptu B; Hall IP; Hanley NA; Heightman M; Hillman TE; Johnson SR; Jones MG; Khan F; Lawson R; Mehta P; Mitchell JA; Platé M; Poinasamy K; Quint JK; Rivera-Ortega P; Semple M; Simpson AJ; Smith D; Spears M; Spencer LG; Stanel SC; Thickett DR; Thompson AAR; Walsh SL; Weatherley ND; Weeks ME; Wootton DG; Brightling CE; Chambers RC; Ho LP; Jacob J; Piper Hanley K; Wain LV; Jenkins RG
    BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34556492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic.
    Wong AW; Fidler L; Marcoux V; Johannson KA; Assayag D; Fisher JH; Hambly N; Kolb M; Morisset J; Shapera S; Ryerson CJ
    Chest; 2020 Sep; 158(3):1069-1078. PubMed ID: 32333929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
    Hyldgaard C; Hilberg O; Pedersen AB; Ulrichsen SP; Løkke A; Bendstrup E; Ellingsen T
    Ann Rheum Dis; 2017 Oct; 76(10):1700-1706. PubMed ID: 28611082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-COVID-19 interstitial lung disease presenting with profound hypoxemia: Report of three cases demonstrating a good response to high-dose corticosteroid therapy.
    Uemasu K; Yasuda Y; Hirayama Y; Arasawa S; Iwashima D; Takahashi KI
    J Infect Chemother; 2022 Feb; 28(2):321-325. PubMed ID: 34810106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.